The STS/ACC TAVR Registry was analyzed to determine the effect of tricuspid regurgitation (TR) on outcomes after transcatheter aortic valve replacement (TAVR). The authors found that TR, of any severity, is quite common in TAVR patients (80%). The breakup of TR severity was as follows:
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
The Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
March 3, 2018
February 21, 2018
A well-written, brief, pessimistic editorial on the loss of surgeon autonomy in innovation.
Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic Valve Replacement
January 16, 2018
In this study with 663 TAVI patients, the authors investigated the predictors for next day discharge (NDD). After excluding cases that did not have a minimalist transfemoral approach, 150 patients had NDD and 210 patients had non-NDD.
January 10, 2018
Folliguet and colleagues report on 145 patients from three French centers who underwent transcarotid aortic valve implantation. The procedures were successful in all. Eight patients suffered a stroke, and one patient had a localized carotid dissection.
January 3, 2018
Video and a readable digest of a talk in a Harvard meeting, especially interesting in its scepticism on prevention.
December 26, 2017
The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) copublished the 2017 guidelines for the management of valvular disease in the European Heart Journal and in the European Journal of Cardio-Thoracic Surgery.
In Global News: Professional Athletes and Large Aortas, the Apple Watch and AFib, and a Second Surgery For Billy Kimmel
December 8, 2017
Patient Care US states that implemented policies for screening newborns for critical congenital heart disease have seen reductions in infant cardiac deaths compared to states that didn’t implement screening.
December 1, 2017
November 16, 2017
This brief article compares costs and morbidities for TAVR and SAVR in the current era. TAVR costs are higher than for SAVR and have increased despite no apparent change in comorbidity index. In contrast, SAVR costs remained stable during the same period.
November 10, 2017